Talcum Powder Litigation Report
Hot on the heels of separate $72 million and $55 million verdicts entered against Johnson & Johnson defendants, HarrisMartin has launched this Talcum Powder Litigation Report, an online-only resource dedicated solely to news on talc-based powder ovarian cancer claims.
SEARCH THE ARCHIVES
Imerys Talc America has filed for an extension of time in which to file its Chapter 11 bankruptcy reorganization plan, the third time it has requested more time in which to file extend the exclusive periods.
A defendant named in a number of ovarian cancer talcum powder cases pending in Florida state court has opposed recent efforts by plaintiffs to consolidate cases pending in the county, maintaining that “consolidation will not conserve the resources of the Court or the parties.”
Fla. Appellate Court Refuses to Stay Asbestos Cosmetic Talc Case While it Considers Jurisdiction Dispute
A Florida appellate court has denied GlaxoSmithKline’s efforts to stay an asbestos cosmetic talcum powder case while it seeks appeal of a lower court order finding that it did, in fact, have jurisdiction over the company.
A New York court has deferred ruling on a motion to dismiss on jurisdiction grounds filed by Johnson & Johnson defendants in an asbestos cosmetic talcum powder case, finding that the plaintiff had “made a ‘sufficient start’ for this court to grant jurisdictional discovery.”
Jury selection had been scheduled to begin this week in the next talcum powder ovarian cancer case to proceed to trial in Missouri, sources confirmed to HarrisMartin.
Issue #36, November 2019
A New York trial court has rejected challenges to forum in an asbestos-containing talcum powder action brought by a Texas woman, saying that the defendant’s ties to New York are enough to prevent dismissal on forum non conveniens grounds.
The Special Master appointed to oversee discovery disputes in the national talcum powder multidistrict litigation docket has weighed in on the dispute relating to the recall of a single lot of Johnson & Johnson’s Baby Powder, outlining testing procedures to be followed in the wake of the announcement.
The FDA has made public the Certificate of Analysis and supporting documentation for the Johnson & Johnson’s Baby Powder sample that tested positive for chrysotile asbestos, according to a recent letter sent to the federal judge overseeing the talcum powder multidistrict litigation docket.
The national talcum powder multidistrict litigation Plaintiffs’ Steering Committee has written another letter to the MDL Judge in regard to the recent recall of a single lot of Baby Powder, saying that Johnson & Johnson made “several inaccurate statements” in its letter to the court.
Issue #35, October 2019
Johnson & Johnson: Baby Powder Recall ‘Doesn’t Move Needle on Whether Plaintiffs Have Scientific Evidence of Causation’
Johnson & Johnson has responded to a letter written by the Plaintiffs’ Steering Committee to the national multidistrict litigation docket for talcum powder claims regarding the defendant’s recent recall of a single lot of Baby Powder, “strongly objecting” the PSC’s suggestion that the recall merits the reopening of the Daubert hearing record.